JP2002512521A5 - - Google Patents

Download PDF

Info

Publication number
JP2002512521A5
JP2002512521A5 JP1999500898A JP50089899A JP2002512521A5 JP 2002512521 A5 JP2002512521 A5 JP 2002512521A5 JP 1999500898 A JP1999500898 A JP 1999500898A JP 50089899 A JP50089899 A JP 50089899A JP 2002512521 A5 JP2002512521 A5 JP 2002512521A5
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP1999500898A
Other languages
English (en)
Japanese (ja)
Other versions
JP2002512521A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US1998/010868 external-priority patent/WO1998054206A1/en
Publication of JP2002512521A publication Critical patent/JP2002512521A/ja
Publication of JP2002512521A5 publication Critical patent/JP2002512521A5/ja
Pending legal-status Critical Current

Links

JP50089899A 1997-05-30 1998-05-28 ３２個のヒト分泌タンパク質 Pending JP2002512521A (ja)

Applications Claiming Priority (19)

Application Number Priority Date Filing Date Title
US4403997P 1997-05-30 1997-05-30
US4835697P 1997-05-30 1997-05-30
US4819097P 1997-05-30 1997-05-30
US4810197P 1997-05-30 1997-05-30
US5093597P 1997-05-30 1997-05-30
US4809397P 1997-05-30 1997-05-30
US60/048,093 1997-05-30
US60/044,039 1997-05-30
US60/048,190 1997-05-30
US60/048,101 1997-05-30
US60/050,935 1997-05-30
US60/048,356 1997-05-30
US5629397P 1997-08-29 1997-08-29
US5625097P 1997-08-29 1997-08-29
US5629697P 1997-08-29 1997-08-29
US60/056,250 1997-08-29
US60/056,293 1997-08-29
US60/056,296 1997-08-29
PCT/US1998/010868 WO1998054206A1 (en) 1997-05-30 1998-05-28 32 human secreted proteins

Publications (2)

Publication Number Publication Date
JP2002512521A JP2002512521A (ja) 2002-04-23
JP2002512521A5 true JP2002512521A5 (enExample) 2005-12-08

Family

ID=27578175

Family Applications (1)

Application Number Title Priority Date Filing Date
JP50089899A Pending JP2002512521A (ja) 1997-05-30 1998-05-28 ３２個のヒト分泌タンパク質

Country Status (11)

Country Link
US (4) US6531447B1 (enExample)
EP (2) EP2332975A1 (enExample)
JP (1) JP2002512521A (enExample)
AT (1) ATE487737T1 (enExample)
AU (1) AU7801998A (enExample)
CA (1) CA2291221A1 (enExample)
CY (1) CY1111950T1 (enExample)
DE (1) DE69841994D1 (enExample)
DK (1) DK1015477T3 (enExample)
PT (1) PT1015477E (enExample)
WO (1) WO1998054206A1 (enExample)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7129061B1 (en) * 1996-08-07 2006-10-31 Biogen Idec Ma Inc. Tumor necrosis factor related ligand
EP0837128A3 (en) * 1996-10-21 1999-04-28 Smithkline Beecham Corporation Human G-protein coupled receptor, HLYAZ61
TW546381B (en) * 1997-04-18 2003-08-11 Chugai Pharmaceutical Co Ltd Transcriptional regulator containing a bromo-domain
US7001992B2 (en) 1997-05-30 2006-02-21 Human Genome Sciences, Inc. Antibodies to secreted protein HEMCM42
ATE487737T1 (de) 1997-05-30 2010-11-15 Human Genome Sciences Inc 32 humane sekretierte proteine
WO2000011942A1 (en) * 1998-09-01 2000-03-09 Gene Logic, Inc. IDENTIFICATION OF A cDNA ASSOCIATED WITH ISCHEMIA IN HUMAN HEART TISSUE
EP1159284A4 (en) * 1999-02-10 2003-10-29 Human Genome Sciences Inc 33 HUMAN SECRETARY PROTEINS
US6372490B1 (en) * 1999-02-23 2002-04-16 Curagen Corporation Nucleic acid encoding the MDM interacting protein
FR2797447B1 (fr) * 1999-08-12 2004-04-02 Univ Clermont Auvergne "odorant-binding" proteines humaines fixant des ligands hydrophobes:polypeptides et polynucleotides codant lesdits polypeptides et leurs applications
CA2387136A1 (en) * 1999-10-29 2001-05-10 Human Genome Sciences, Inc. 26 human secreted proteins
JP2003515320A (ja) * 1999-10-29 2003-05-07 ヒューマン ジノーム サイエンシーズ， インコーポレイテッド ２５個のヒト分泌タンパク質
JP5148795B2 (ja) 1999-12-20 2013-02-20 イミュネックス・コーポレーション Ｔｗｅａｋ受容体
US6727225B2 (en) 1999-12-20 2004-04-27 Immunex Corporation TWEAK receptor
EP1174502A1 (en) * 2000-07-18 2002-01-23 Schering Corporation Type 2 dendritic cell precursor derived coding nucleic acids and related compositions and methods
HUE025101T2 (en) 2002-04-26 2016-02-29 Genentech Inc Purification of proteins other than affinity purification
WO2005010045A1 (en) 2003-07-24 2005-02-03 Amgen Inc. Compositions and methods relating to multimeric and oligomeric soluble fragments of the tweak receptor
DK2332408T3 (da) 2005-02-17 2013-12-02 Biogen Idec Inc Behandling af neurologiske sygdomme
CA2607697C (en) 2005-05-10 2015-01-06 Biogen Idec Ma Inc. Treating and evaluating inflammatory disorders
EP1876448A1 (en) * 2005-09-30 2008-01-09 DIGILAB BioVisioN GmbH Method and analytical reagents for identifying therapeutics using biomarkers responsive to thiazolidinediones.
HUE027057T2 (en) 2007-07-27 2016-08-29 Immatics Biotechnologies Gmbh New immunogenic epitope for immunotherapy
MX2010001378A (es) 2007-08-03 2010-06-02 Facet Biotech Corp Uso terapeutico de anticuerpos del receptor anti-tweak.
GB0809592D0 (en) * 2008-05-27 2008-07-02 Imp Innovations Ltd Biomaterials

Family Cites Families (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US912292A (en) * 1907-05-03 1909-02-16 Morris E Curtis Machine for making tubes.
US912293A (en) * 1908-02-03 1909-02-16 Nat Regulator Company Temperature-regulating device.
US3773919A (en) 1969-10-23 1973-11-20 Du Pont Polylactide-drug mixtures
US4263428A (en) 1978-03-24 1981-04-21 The Regents Of The University Of California Bis-anthracycline nucleic acid function inhibitors and improved method for administering the same
ATE12348T1 (de) 1980-11-10 1985-04-15 Gersonde Klaus Prof Dr Verfahren zur herstellung von lipid-vesikeln durch ultraschallbehandlung, anwendung des verfahrens und vorrichtung zur durchfuehrung des verfahrens.
IE52535B1 (en) 1981-02-16 1987-12-09 Ici Plc Continuous release pharmaceutical compositions
US4485045A (en) 1981-07-06 1984-11-27 Research Corporation Synthetic phosphatidyl cholines useful in forming liposomes
JPS58118008A (ja) 1982-01-06 1983-07-13 Nec Corp デ−タ処理装置
EP0088046B1 (de) 1982-02-17 1987-12-09 Ciba-Geigy Ag Lipide in wässriger Phase
EP0102324A3 (de) 1982-07-29 1984-11-07 Ciba-Geigy Ag Lipide und Tenside in wässriger Phase
US4816567A (en) 1983-04-08 1989-03-28 Genentech, Inc. Recombinant immunoglobin preparations
US4544545A (en) 1983-06-20 1985-10-01 Trustees University Of Massachusetts Liposomes containing modified cholesterol for organ targeting
HUT35524A (en) 1983-08-02 1985-07-29 Hoechst Ag Process for preparing pharmaceutical compositions containing regulatory /regulative/ peptides providing for the retarded release of the active substance
DE3486459D1 (de) 1983-09-26 1997-12-11 Udo Dr Med Ehrenfeld Mittel und Erzeugnis für die Diagnose und Therapie von Tumoren sowie zur Behandlung von Schwächen der zelligen und humoralen Immunabwehr
EP0143949B1 (en) 1983-11-01 1988-10-12 TERUMO KABUSHIKI KAISHA trading as TERUMO CORPORATION Pharmaceutical composition containing urokinase
JPS6147500A (ja) 1984-08-15 1986-03-07 Res Dev Corp Of Japan キメラモノクロ−ナル抗体及びその製造法
EP0173494A3 (en) 1984-08-27 1987-11-25 The Board Of Trustees Of The Leland Stanford Junior University Chimeric receptors by dna splicing and expression
GB8422238D0 (en) 1984-09-03 1984-10-10 Neuberger M S Chimeric proteins
US4631211A (en) 1985-03-25 1986-12-23 Scripps Clinic & Research Foundation Means for sequential solid phase organic synthesis and methods using the same
WO1987001130A1 (en) 1985-08-15 1987-02-26 Stauffer Chemical Company Tryptophan producing microorganism
JPS63501765A (ja) 1985-11-01 1988-07-21 インタ−ナショナル、ジェネティック、エンジニアリング　インコ−ポレ−テッド 抗体遺伝子のモジュ−ル組立体、それにより産生された抗体及び用途
US5128256A (en) 1987-01-12 1992-07-07 Stratagene DNA cloning vectors with in vivo excisable plasmids
EP0394827A1 (en) 1989-04-26 1990-10-31 F. Hoffmann-La Roche Ag Chimaeric CD4-immunoglobulin polypeptides
DE59109269D1 (de) 1990-06-28 2005-12-15 Hoechst Ag Fusionsproteine mit Immunglobulinanteilen, ihre Herstellung und Verwendung
IL111125A0 (en) * 1994-05-11 1994-12-29 Yeda Res & Dev Soluble oligomeric tnf/ngf super family ligand receptors and their use
CA2220123A1 (en) 1995-05-05 1996-11-07 Human Genome Sciences, Inc. Human chemokine beta-8, chemokine beta-1 and macrophage inflammatory protein-4
FR2741075B1 (fr) * 1995-11-15 1998-01-30 Rech De Pathologie Appliquee S Conjugues peptidiques, leur utilisation a titre de medicament et compositions les contenant
CA2280231A1 (en) 1997-02-12 1998-08-13 Abbott Laboratories Member of the tnf family useful for treatment and diagnosis of disease
ATE487737T1 (de) 1997-05-30 2010-11-15 Human Genome Sciences Inc 32 humane sekretierte proteine
AU7549498A (en) * 1997-06-03 1998-12-21 Protegene Inc. Human proteins having transmembrane domains and dnas encoding these prot eins
US6051385A (en) * 1997-10-22 2000-04-18 The Regents Of The University Of Michigan Compositions and methods for identifying and testing therapeutics against HSV infection
CA2329072A1 (en) 1998-05-29 1999-12-02 Incyte Pharmaceuticals, Inc. Human transmembrane proteins
JP5148795B2 (ja) * 1999-12-20 2013-02-20 イミュネックス・コーポレーション Ｔｗｅａｋ受容体

Similar Documents

Publication Publication Date Title
JP2000509912A5 (enExample)
JP2000510751A5 (enExample)
JP2000509942A5 (enExample)
JP2000507042A5 (enExample)
JP2001513925A5 (enExample)
JP2001510366A5 (enExample)
JP2001515682A5 (enExample)
JP2001504864A5 (enExample)
JP2000507369A5 (enExample)
JP2000507433A5 (enExample)
JP2001519086A5 (enExample)
JP2000508866A5 (enExample)
JP2000510793A5 (enExample)
JP2000508022A5 (enExample)
JP2000508841A5 (enExample)
JP2002504172A5 (enExample)
JP2000508680A5 (enExample)
JP2000509804A5 (enExample)
JP2000509853A5 (enExample)
JP2000509755A5 (enExample)
JP2000510247A5 (enExample)
JP2000510969A5 (enExample)
JP2000508102A5 (enExample)
JP2000508836A5 (enExample)
JP2002512521A5 (enExample)